Genpact Stock Extends An 11-Day Losing Streak To A 12% Loss
A persistent slide in Genpact stock prompts a fresh look at the business behind the ticker.
Genpact (G) stock has now moved lower for 11 consecutive trading days, a cumulative loss of 11.5%. That streak has erased about $708 million from the company’s market value, which now stands at about $5.5 billion.
Even with the 11-day decline included, the stock remains up +17.9% over the trailing three months.
How The Streak Stacks Up Against The S&P 500
Here is how G stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | G | S&P 500 |
|---|---|---|
| 1D | -1.1% | -0.2% |
| 11D (Current Streak) | -11.5% | 0.7% |
| 1M (21D) | -14.7% | -0.5% |
| 3M (63D) | 17.9% | 2.3% |
| YTD 2026 | -30.0% | 12.1% |
| 2025 | 10.6% | 16.4% |
| 2024 | 25.8% | 23.3% |
| 2023 | -24.0% | 24.2% |
A Look At Underlying Business Fundamentals
The decline diverged sharply from the broader market, as the S&P 500 gained +0.7% over the same 11 trading days. The business itself remains profitable, with an operating margin of 15.0% over the last twelve months. Its revenue grew 6.5% over the same period.
Both figures trail broader Industrials and business services sector medians of 17.6% and 7.3% respectively. Yet the stock trades at a price-to-earnings multiple of 9.4, well below the sector median of 26.7. Genpact stock trades at about $32.24 a share as of 9/29/2026.
A Streak Is Information, Not An Instruction.
A streak of this length is a signal about momentum and market attention. It is not a command to buy or sell. For a disciplined investor, a sharp move in either direction is a reason to re-evaluate the relationship between the company’s price and its underlying business. The data here offers a starting point for that work.
A drawdown of this magnitude poses an obvious follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.
And for anyone who would rather back the theme than one company’s story, our ETF Scorecard shows how the U.S. industrials funds stack up. Any one of those funds is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.
A Slide Like This Is Why Diversification Exists
Watching one stock fall day after day is the clearest lesson the market teaches about single-name risk. Whether this particular decline is an opportunity or a warning, the deeper point is the same: no one name should be able to do this to your portfolio.
The Trefis High Quality (HQ) Portfolio is built on that principle: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Study the slide; spread the risk.